The Role of Serum Amyloid A in Predicting Short Term Preterm Labor
DOI:
https://doi.org/10.51984/joms.v17i2.2427Keywords:
Preterm labor, Prediction, serum amyloid A, C-reactive proteinAbstract
Background: preterm labour ( PL) is a major contributor to prenatal morbidity and mortality, defined by birth before completed 37 weeks of pregnancy. Not all cases with threatened PL end with labor; the reason is unclear. Many accredited infections as a cause for PL. We hypothesized that serum amyloid A (SAA), an acute-phase inflammatory reactant, may be used in predicting cases that proceed rapid PL. Material and methods: A prospective case-control study recruited 70 participants from the gynecology department of our University Hospital. All presented with threatened PL with intact membrane; in gestational age of 28-36 weeks of a singleton viable cephalic pregnancy. Detailed history and physical examination were made, and venous blood samples were aspirated and divided into two parts for CRP assessment and SAA estimation by ELIZA Kit. Patients were followed 31/70 delivered in 1 week times assigned as the study group, and the rest 39/70 were discharged home and continued pregnancy assigned as healthy controls. Results: Maternal serum SAA, CRP, and Gestational age were strongly significant as P<0.001. Significantly High serum SAA in the cases versus healthy controls. The ROC defines the SAA cutoff value by 27.2, AUC 0.92, P<0.001. Conclusion: SAA strongly correlated with gestational age r =0.52, with 90% sensitivity and specificity implying a reliable predictor for short-term PL. It outstands CRP in performance. An accurate test for the prediction of preterm labor is an urgent necessity. It allows vigorous monitoring and implementation of preventive measures aimed to improve neonatal outcomes.
Downloads
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2023 Journal of Medical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This article is published open access under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). You may copy, redistribute, adapt and build upon it for non-commercial purposes, provided you credit the authors, cite the original publication in the Journal of Medical Sciences with its DOI, indicate any changes, and distribute any adaptations under the same licence. Copyright rests with the authors. For commercial reuse, please contact the corresponding author. Full terms: https://sebhau.edu.ly/journal/joms/copyright-licensing




















